BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 26, 2010
View Archived Issues
SkyePharma receives FDA complete response letter regarding NDA for Flutiform
Read More
FDA sets PDUFA date for Genzyme's BLA for Lumizyme
Read More
Biogen and Swedish Orphan Biovitrum initiate dosing in B-LONG trial of rFIXFc in hemophilia B
Read More
Bayer to discontinue phase II trial of recombinant liposomal factor VIII
Read More
Clinical data shows nilotinib to be an effective front-line treatment for CML
Read More
Clinical data show safety and efficacy of dasatinib as initial therapy for CML
Read More
Shionogi discloses N-type calcium channel blockers as analgesics
Read More
Dana-Farber Cancer Institute claims novel antimalarials
Read More
Novel prostacyclin and carbaprostacyclin prodrugs in early development at Gilead
Read More
Amnestix describes novel kinase inhibitors for the treatment of cognitive disorders
Read More
Merck KGaA claims tyrosine kinase inhibitors for the treatment of cancer
Read More
Spectrum meets with FDA regarding Fusilev sNDA for colorectal cancer
Read More
Proangiogenic gene therapy reduces ventricular remodeling in diabetic rats
Read More
Roche presents OX-2 receptor antagonists for the treatment of sleep disorders
Read More
KV-11 shows preclinical potential as ocular antiangiogenic therapy
Read More
Affymax completes treatment in phase III trial of Hematide for anemia in CRF
Read More
Janssen-Cilag notifies EMEA of withdrawal of Comfyde MAA for partial-onset seizures
Read More
Merck & Co. claims novel PET imaging agents for the diagnosis of AD
Read More
Osiris completes enrollment in phase II trial of Prochymal in type 1 diabetes
Read More
Prolor Biotech reports preclinical results on interferon beta-CTP for multiple sclerosis
Read More
Anadys provides progress update on phase II study of ANA-598 in hepatitis C
Read More
EMEA recommends additional measures to manage risk for PML with Tysabri therapy
Read More
CHMP recommends suspension of marketing authorization for sibutramine
Read More
Transition Therapeutics reports results from phase II trial of TT-223 in type 2 diabetes
Read More
European Commission approves Bristol-Myers' Orencia in combination with MTX for pJIA
Read More
Dr. Reddy's and Aegis sign partnership agreement on Intravail drug delivery technology
Read More